Hematopoietic Cell Transplantation with Cord Blood for Cure of HIV Infections

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 3, 2013, Pages 393-397

  Petz, Lawrence D ^a   Redei, Istvan ^b   Bryson, Yvonne ^c   Regan, Donna ^d   Kurtzberg, Joanne ^e   Shpall, Elizabeth ^f   Gutman, Jonathan ^g   Querol, Sergio ^h   Clark, Pamela ⁱ   Tonai, Richard ^a   Santos, Sarah ^a   Bravo, Aide ^a   Spellman, Stephen ^j   Gragert, Loren ^j   Rossi, John ^k   Li, Shirley ^k   Li, Haitang ^k   Senitzer, David ^k   Zaia, John ^k   Rosenthal, Joseph ^k   Forman, Stephen ^k   Chow, Robert ^l   more..

^a StemCyte   (United States)

^b Midwestern Regional Medical Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SSM Cardinal Glennon Children's Medical Center   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF COLORADO HOSPITAL   (United States)

^h Barcelona Cord Blood Bank   (Spain)

ⁱ Sydney Cord Blood Bank   (Australia)

^j NATIONAL MARROW DONOR PROGRAM   (United States)

^k CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^l HMD Consulting   (United States)

more..

Author keywords

CCR5 32 32 donors; Cord blood transplantation; Cure of HIV infections; Hematopoietic cell transplantation

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; DNA ISOLATION; DONOR; ETHNIC GROUP; GENOTYPE; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; RECIPIENT; SCREENING; UMBILICAL CORD BLOOD;

ADULT; BLOOD BANKS; CELLS, CULTURED; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISTOCOMPATIBILITY TESTING; HIV INFECTIONS; HLA ANTIGENS; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; PROBABILITY; RECEPTORS, CCR5; SEQUENCE DELETION; TRANSPLANTATION CHIMERA; UNRELATED DONORS;

EID: 84873738309     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.10.017     Document Type: Article

References (38)

1. Berger E.A., Doms R.W., Fenyo E.M., et al. A new classification for HIV-1. Nature 1998, 391:240.
2. Samson M., Libert F., Doranz B.J., et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
3. Liu R., Paxton W.A., Choe S., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86:367-377.
4. Zimmerman P.A., Buckler-White A., Alkhatib G., et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 1997, 3:23-36.
5. Hütter G., Nowak E., Mossner M. Long-term control of HIV by CCR5 Delta32/Delta32 stem cell transplantation. N Engl J Med 2009, 360:692-698.
6. Hütter G., Ganepola S. Eradication of HIV by transplantation of CCR5-deficient hematopoietic stem cells. Sci World J 2011, 11:1068-1076.
7. Allers K., Hutter G., Hofmann J., et al. Evidence for the cure of HIV infection by CCR5{Delta}32/{Delta}32 stem cell transplantation. Blood 2011, 117:2791-2799.
8. Deeks S.G., McCune J.M. Can HIV be cured with stem cell therapy?. Nat Biotechnol 2010, 28:807-810.
9. Martinson J.J., Chapman N.H., Rees D.C., et al. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997, 16:100-103.
10. Ruiz-Ferrer M., Barroso N., Antinolo G., Guilar-Reina J. Analysis of CCR5-Δ 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fluorescence resonance energy transfer technologies. J Viral Hepat 2004, 11:319-323.
11. Gonzalez G., Park S., Chen D., et al. Identification and frequency of CCR5Δ32/Δ32 HIV-resistant cord blood units from Houston area hospitals. HIV Med 2011, 12:481-486.
12. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
13. Hütter G., Thiel E. Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2. AIDS 2011, 25:273-274.
14. Smith A.R., Wagner J.E. Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. Br J Haematol 2009, 147:246-261.
15. Kollman C., Abella E., Baitty R.L., et al. Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. Transplantation 2004, 78:89-95.
16. Howard D.H., Meltzer D., Kollman C., et al. Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. Med Decis Making 2008, 28:243-253.
17. Kollman C., Maiers M., Gragert L., et al. Estimation of HLA-A, -B, -DRB1 haplotype frequencies using mixed resolution data from a National Registry with selective retyping of volunteers. Hum Immunol 2007, 68:950-958.
18. Novembre J., Galvani A.P., Slatkin M. The geographic spread of the CCR5 Delta32 HIV-resistance allele. PLoS Biol 2005, 3:e339.
19. Liu H., Rich E.S., Godley L., et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood 2011, 118:6438-6445.
20. Smith A.R., Baker K.S., DeFor T.E., et al. Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors. Biol Blood Marrow Transplant 2009, 15:1086-1093.
21. Tomblyn M.B., Arora M., Baker K.S., et al. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. J Clin Oncol 2009, 27:3634-3641.
22. Gutman J.A., Leisenring W., Appelbaum F.R., et al. Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis. Biol Blood Marrow Transplant 2009, 15:1122-1129.
23. Takahashi S., Ooi J., Tomonari A., et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007, 109:1322-1330.
24. Eapen M., Rocha V., Sanz G., et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010, 11:653-660.
25. Brunstein C.G., Gutman J.A., Weisdorf D.J., et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 2010, 116:4693-4699.
26. Zhang M.J., Davies S.M., Camitta B.M., et al. Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2012, 18:1204-1210.
27. Petz L.D., Spellman S., Gragert L. The underutilization of cord blood transplantation-extent of the problem, causes and methods of improvement. Cord blood biology, transplantation, banking, and regulatory considerations 2011, 557-584. AABB Press, Bethesda, MD. H. Broxmeyer (Ed.).
28. Hütter G., Zaia J.A. Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. Clin Exp Immunol 2011, 163:284-295.
29. Krishnan A., Forman S.J. Hematopoietic stem cell transplantation for AIDS-related malignancies. Curr Opin Oncol 2010, 22:456-460.
30. Krishnan A., Palmer J.M., Zaia J.A., et al. HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL). Biol Blood Marrow Transplant 2010, 16:1302-1308.
31. DiGiusto D.L., Krishnan A., Li L., et al. RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med 2010, 2:36-43.
32. Krishnan A., Zaia J., Rossi J., et al. First in human engraftment of anti-HIV lentiviral vector gene modified peripheral blood progenitor cells in the treatment of AIDS related lymphoma. Blood 2001, 112:2348a. [abstract].
33. Scherer L.J., Rossi J.J. Ex vivo gene therapy for HIV-1 treatment. Hum Mol Genet 2011, 20(R1):R100-R107.
34. Perez E.E., Wang J., Miller J.C., et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 2008, 26:808-816.
35. Rahman S.H., Maeder M.L., Joung J.K., Cathomen T. Zinc-finger nucleases for somatic gene therapy: the next frontier. Hum Gene Ther 2011, 8:925-933.
36. Kay M.A. State-of-the-art gene-based therapies: the road ahead. Nat Rev Genet 2011, 12:316-328.
37. Riviere I., Dunbar C.E., Sadelain M. Hematopoietic stem cell engineering at a crossroads. Blood 2012, 119:1107-1116.
38. Lai Y. Adopting autologous hematopoietic stem cells with non-functional CCR5 and CXCR4 against HIV. Bone Marrow Transplant 2010, 45:770-771. [abstract].